Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal A Verma

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|September 11, 2020
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical IngredientsChristian Gampe, Vishal A Verma
Organic Letters|July 1, 2008
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinityPaul A Wender, Vishal A Verma
Organic Letters|April 21, 2006
Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatinPaul A Wender, Vishal A Verma
Organic Letters|November 3, 2006
Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogsPaul A Wender, Joshua C Horan, Vishal A Verma
Accounts of Chemical Research|December 28, 2007
Function-oriented synthesis, step economy, and drug designPaul A Wender, Vishal A Verma, Thomas J Paxton, et al.
Molecular Carcinogenesis|September 25, 2004
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformationJavier A Menendez, Inderjit Mehmi, Vishal A Verma, et al.
Neurobiology of Disease|February 24, 2009
A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblastsTapan K Khan, Thomas J Nelson, Vishal A Verma, et al.
Oncogene|April 20, 2004
Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cellsJavier A Menendez, Bharvi P Oza, Ella Atlas, et al.
Nature Chemical Biology|December 24, 2005
Actin is the primary cellular receptor of bistramide AAlexander V Statsuk, Ruoli Bai, Jeremy L Baryza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2011
Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivityPaul A Wender, Jeremy L Baryza, Stacey E Brenner, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|September 11, 2020
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical IngredientsChristian Gampe, Vishal A Verma
Organic Letters|July 1, 2008
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinityPaul A Wender, Vishal A Verma
Organic Letters|April 21, 2006
Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatinPaul A Wender, Vishal A Verma
Organic Letters|November 3, 2006
Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogsPaul A Wender, Joshua C Horan, Vishal A Verma
Accounts of Chemical Research|December 28, 2007
Function-oriented synthesis, step economy, and drug designPaul A Wender, Vishal A Verma, Thomas J Paxton, et al.
Molecular Carcinogenesis|September 25, 2004
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformationJavier A Menendez, Inderjit Mehmi, Vishal A Verma, et al.
Neurobiology of Disease|February 24, 2009
A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblastsTapan K Khan, Thomas J Nelson, Vishal A Verma, et al.
Oncogene|April 20, 2004
Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cellsJavier A Menendez, Bharvi P Oza, Ella Atlas, et al.
Nature Chemical Biology|December 24, 2005
Actin is the primary cellular receptor of bistramide AAlexander V Statsuk, Ruoli Bai, Jeremy L Baryza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2011
Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivityPaul A Wender, Jeremy L Baryza, Stacey E Brenner, et al.
Pageof 3